131
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Comparison of chemoembolization with CalliSpheres® microspheres and conventional chemoembolization in the treatment of hepatocellular carcinoma: a multicenter retrospective study

, , , , , , , , , , , , , , , , & show all
Pages 941-956 | Published online: 10 Feb 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Lijie Zhang, Wei Hong, Zizhuo Wang, Chuansheng Zheng, Bin Liang & Heshui Shi. (2023) Safety and Effectiveness of Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Aged Greater versus Less Than 80 Years. Clinical Interventions in Aging 18, pages 1883-1892.
Read now
Kun Ji, Hanlong Zhu, Wei Wu, Xin Li, Pengchao Zhan, Yang Shi, Junhui Sun & Zhen Li. (2022) Tumor Response and Nomogram-Based Prognostic Stratification for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization. Journal of Hepatocellular Carcinoma 9, pages 537-551.
Read now
Liang Cai, Honglu Li, Jiang Guo, Wenpeng Zhao, Youjia Duan, Xiaopu Hou, Long Cheng, Hongliu Du, Xihong Shao, Zhenying Diao, Yiwei Hao, Xinmei Zheng, Changqing Li & Wei Li. (2022) Treatment efficacy and safety of drug-eluting beads transarterial chemoembolization versus conventional transarterial chemoembolization in hepatocellular carcinoma patients with arterioportal fistula. Cancer Biology & Therapy 23:1, pages 89-95.
Read now
Andrew S. Mikhail, Ayele H. Negussie, Michal Mauda-Havakuk, Joshua W. Owen, William F. Pritchard, Andrew L. Lewis & Bradford J. Wood. (2021) Drug-eluting embolic microspheres: State-of-the-art and emerging clinical applications. Expert Opinion on Drug Delivery 18:3, pages 383-398.
Read now
Guangsheng Zhao, Song Liu, Songbai Chen, Zhizhong Ren, Chuang Li, Jie Bian, Jianlin Wu, Jun Zhou & Yuewei Zhang. (2021) Assessment of efficacy and safety by CalliSpheres versus HepaSpheres for drug-eluting bead transarterial chemoembolization in unresectable large hepatocellular carcinoma patients. Drug Delivery 28:1, pages 1356-1362.
Read now

Articles from other publishers (12)

Nur Aisyah Nuzulia, Terry Mart, Ifty AhmedYessie Widya Sari. (2024) The Use of Microspheres for Cancer Embolization Therapy: Recent Advancements and Prospective. ACS Biomaterials Science & Engineering 10:2, pages 637-656.
Crossref
Zhongxing Shi, Dongqing Wang, Tanrong Kang, Ru Yi, Liming Cui & Huijie Jiang. (2023) Comparison of CalliSpheres ® microspheres drug-eluting beads and conventional transarterial chemoembolization in hepatocellular carcinoma patients: a randomized controlled trial . Radiology and Oncology 57:1, pages 70-79.
Crossref
Lijie Zhang, Xin Zhang, Qing Li, Joyman Makamure, Ziyi Liu, Dan Zhao, Xin Li, Heshui Shi, Chuansheng Zheng, Fengyong Liu & Bin Liang. (2023) Transarterial chemoembolization failure in patients with hepatocellular carcinoma: Incidence, manifestation and risk factors. Clinics and Research in Hepatology and Gastroenterology 47:2, pages 102071.
Crossref
Zi Wang, Ketao Mu, Yinzhang Lv, Lingyun Zhao, Basen Li, Yonghong Hao & Nan Wang. (2022) Efficacy, safety, and prognostic factors of drug-eluting beads transarterial chemoembolization using CalliSpheres in treating huge hepatocellular carcinoma patients. Irish Journal of Medical Science (1971 -) 191:6, pages 2493-2499.
Crossref
Wenhui Wang, Fenqiang Li, Peiying Gan, Baohua Li & Shuangxi Li. (2022) Callispheres drug-eluting bead transhepatic artery chemoembolization with oral delivery of sorafenib for the treatment of unresectable liver cancer. Frontiers in Surgery 9.
Crossref
Guangsheng Zhao, Song Liu, Ying Liu, Xiang Li, Guangji Yu, Yuewei Zhang, Jie Bian, Jianlin Wu, Jun Zhou & Fei Gao. (2022) CalliSpheres® microsphere transarterial chemoembolization combined with 125I brachytherapy for patients with non–small‐cell lung cancer liver metastases. Frontiers in Oncology 12.
Crossref
Qin Shi, Jiacheng Liu, Tongqiang Li, Chen Zhou, Yingliang Wang, Songjiang Huang, Chongtu Yang, Yang Chen & Bin Xiong. (2022) Comparison of DEB-TACE and cTACE for the initial treatment of unresectable hepatocellular carcinoma beyond up-to-seven criteria: A single-center propensity score matching analysis. Clinics and Research in Hepatology and Gastroenterology 46:5, pages 101893.
Crossref
Tianshi Lyu, Hang Yao, Jian Wang, Li Song, Xiaoqiang Tong & Yinghua Zou. (2022) Treatment response, survival and safety profile of transarterial chemoembolization using different sizes of drug-eluting beads in hepatocellular carcinoma patients with portal vein tumor thrombus. Clinics and Research in Hepatology and Gastroenterology 46:4, pages 101819.
Crossref
Zhi-Min Zou, De-Hua Chang, Hui Liu & Yu-Dong Xiao. (2021) Current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know?. Insights into Imaging 12:1.
Crossref
Liang Cai, Honglu Li, Jiang Guo, Wenpeng Zhao, Youjia Duan, Xiaopu Hou, Long Cheng, Hongliu Du, Xihong Shao, Zhenying Diao & Changqing Li. (2021) Drug-eluting bead transarterial chemoembolization is an effective downstaging option for subsequent radical treatments in patients with hepatocellular carcinoma: A cohort study. Clinics and Research in Hepatology and Gastroenterology 45:4, pages 101535.
Crossref
Bin Liang, Joyman Makamure, Shenglei Shu, Lijie Zhang, Tao Sun & Chuansheng Zheng. (2021) Treatment Response, Survival, and Safety of Transarterial Chemoembolization With CalliSpheres® Microspheres Versus Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma: A Meta-Analysis. Frontiers in Oncology 11.
Crossref
Xiaohong Li, Xiongfa Ji, Kun Chen, Xi Yuan, Zehua Lei, Muhammad Wajid Ullah, Jun Xiao & Guang Yang. (2021) Preparation and evaluation of ion-exchange porous polyvinyl alcohol microspheres as a potential drug delivery embolization system. Materials Science and Engineering: C 121, pages 111889.
Crossref